NCT00461396 - Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron | Biotech Hunter

Enrollment

104

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

June 30, 2009

Study Completion Date

November 30, 2009

Conditions

Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting

Interventions

DRUG

Interferon-1beta (Betaseron, BAY86-5046)

Male and females, 18 to 50 years of age, after a first clinical demyelinating event suggestive of multiple sclerosis or with onset of RRMS within the past 12 months

Trial Locations (19)

Unknown

Many Locations